ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 59 filers reported holding ADICET BIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $378,599 | -5.9% | 65,729 | +46.1% | 0.52% | +104.3% |
| Q4 2022 | $402,300 | -37.1% | 45,000 | 0.0% | 0.26% | -0.8% |
| Q3 2022 | $640,000 | -77.8% | 45,000 | -77.3% | 0.26% | -64.9% |
| Q2 2022 | $2,889,000 | -26.9% | 197,898 | 0.0% | 0.74% | -10.7% |
| Q1 2022 | $3,952,000 | +14.2% | 197,898 | 0.0% | 0.82% | +40.8% |
| Q4 2021 | $3,461,000 | +123.0% | 197,898 | 0.0% | 0.59% | +392.4% |
| Q3 2021 | $1,552,000 | -36.0% | 197,898 | -16.1% | 0.12% | +32.2% |
| Q2 2021 | $2,426,000 | -22.7% | 235,748 | -1.8% | 0.09% | -23.1% |
| Q1 2021 | $3,139,000 | – | 240,000 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |